# VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

> **NCT00004216** · PHASE1 · COMPLETED · sponsor: **Vion Pharmaceuticals**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** salmonella VNP20009
- **DRUG:** cefixime
- **DRUG:** ceftriaxone sodium
- **DRUG:** ciprofloxacin
- **DRUG:** trimethoprim-sulfamethoxazole

## Key facts

- **NCT ID:** NCT00004216
- **Lead sponsor:** Vion Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** —
- **Final completion:** 2008-01
- **Target enrollment:** — (—)
- **Last updated:** 2013-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004216, "VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00004216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*